Company Pharos iBio Co., Ltd.

Equities

A388870

KR7388870008

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
10,750 ^KRW	+1.22%		-9.36%	-27.51%

2023	Pharos Therapeutics INC announced that it has received KRW 1.3523 billion in funding from Pharos iBio Co., Ltd.	CI
2023	Pharos Therapeutics INC announced that it expects to receive KRW 1.3523 billion in funding from Pharos iBio Co., Ltd.	CI

Pharos IBio Co Ltd is a Korea-based company principally engaged in the research and development of new drugs. The Company principally engaged in the research and development of new drugs such as treatments for rare and intractable diseases. The Company is engaged in the development of treatments for rare and intractable diseases such as relapse-refractory ovarian cancer, acute myeloid leukemia, triple-negative breast cancer, recurrent acute myeloid leukemia as well as others.

Managers	Title	Age	Since
Jung-Hyuk Yoon CEO	Chief Executive Officer	60	18/04/16
Sung-Won Mun DFI	Director of Finance/CFO	48	31/12/17
Ky-Youb Nam PSD	President	52	30/04/16
Hye-Jung Han PSD	President	57	29/02/20
Chong-Chul Chai CTO	Chief Tech/Sci/R&D Officer	54	30/11/21
Jang-Hwan Kim AUD	Comptroller/Controller/Auditor	59	31/07/18
Gyu-Tae Kim PRN	Corporate Officer/Principal	57	-

Members of the board	Title	Age	Since
Jung-Hyuk Yoon CEO	Chief Executive Officer	60	18/04/16
Hye-Jung Han PSD	President	57	29/02/20
Ky-Youb Nam PSD	President	52	30/04/16
Sung-Won Mun DFI	Director of Finance/CFO	48	31/12/17
Sang-Bok Lee BRD	Director/Board Member	62	27/03/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,918,962	7,318,968 ( 56.65 %)	0	56.65 %

Name	Equities	%	Valuation
Yoon Jeong Hyeok 21.21 %	2,740,358	21.21 %	24 M ₩
Jung-Hyuk Yoon 21.21 %	2,740,358	21.21 %	24 M ₩
Ky-Youb Nam 4.911 %	634,500	4.911 %	6 M ₩
Company K Partners Ltd. (Private Equity) 4.724 %	610,346	4.724 %	5 M ₩
Mirae Asset Capital Co., Ltd. 3.634 %	469,519	3.634 %	4 M ₩
Korea Development Bank (Private Equity) 2.787 %	360,045	2.787 %	3 M ₩
Hye-Jung Han 2.718 %	351,180	2.718 %	3 M ₩
Sung-Won Mun 2.076 %	268,210	2.076 %	2 M ₩
Jae-hee Yoon 1.161 %	150,000	1.161 %	1 M ₩
Yoon Hee Soo 1.161 %	150,000	1.161 %	1 M ₩

Pharos iBio Co., Ltd.

Room 1407 & 1408, 38 Heungan-daero 427beon-gil

14059, Anyang-si

http://www.pharosibio.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
PHAROS IBIO CO., LTD.	-27.51%	101M
VERTEX PHARMACEUTICALS INCORPORATED	+15.20%	121B
REGENERON PHARMACEUTICALS, INC.	+19.67%	113B
ARGENX SE	+18.95%	26.02B
BIONTECH SE	-23.86%	19.39B
GENMAB A/S	-19.03%	15.91B
BEIGENE, LTD.	-20.90%	15.09B
WUXI APPTEC CO., LTD.	-46.14%	15.06B
SAREPTA THERAPEUTICS, INC.	+63.85%	14.93B
NEUROCRINE BIOSCIENCES, INC.	+4.49%	13.85B

Bio Therapeutic Drugs